Date: March 9, 2016
New Report Provides Recommendations for Improving Social Security Administration’s Process for Determining Whether Adult Beneficiaries Are Capable of Managing Their Financial Benefits
WASHINGTON – The best indicator of whether a disabled adult who receives Social Security benefits is capable of managing his or her benefits is evidence of real-world performance of meeting his or her own basic needs, rather than an office-based assessment of financial competence, says a new report from the National Academies of Sciences, Engineering, and Medicine. In such a performance-based process, information from people who are in direct contact with the beneficiary and in a position to know about his or her financial performance is particularly helpful. The committee that carried out the study and wrote the report evaluated the U.S. Social Security Administration’s (SSA) process of determining whether adult beneficiaries with disabilities are capable of managing their benefits and made recommendations to inform and guide efforts to improve the current process.
SSA provides benefits to more than 16 million disabled adults, of whom approximately 3.5 million have been deemed incapable of managing or directing the management of their benefits. For those individuals, a representative payee is appointed to receive the SSA payments and ensure that they are used first to meet beneficiaries’ basic needs for shelter, food, and clothing.
The decision to appoint a representative payee entails weighing the beneficiary’s personal autonomy and preferences against interventions meant to protect his or her best interests, the committee said. Because appointment of a representative payee affects the beneficiary’s autonomy, it should occur only when clearly necessary to ensure that the beneficiary’s basic needs are met. However, reports from the SSA Office of the Inspector General suggest that SSA’s current process may be identifying too few beneficiaries who could be helped with a representative payee. Except for a limited number of conditions -- such as a coma lasting at least 30 days or an IQ of 59 or less -- SSA currently has no standardized process for identifying individuals who may be in need of a capability evaluation. In addition, SSA’s lack of a formal process for periodically reviewing the capabilities of beneficiaries who are at risk for becoming incapable or have been determined incapable is a significant weakness, the committee said, as some mechanism for periodic reassessment is needed to ensure that beneficiaries with fluctuating, deteriorating, or improving financial capability are classified accurately. SSA create a data-driven process to develop approaches, including screening criteria, for identifying people at high risk for financial incapability, as well as create systematic mechanisms for recognizing and responding to changes in beneficiaries’ capability over time.
SSA beneficiaries may receive benefits from both SSA’s Supplemental Security Income and Social Security Disability Insurance programs, yet some have been assigned a representative payee in one program but not the other. SSA beneficiaries also may receive benefits from other federal agencies, such as the U.S. Department of Veterans Affairs or the U.S. Office of Personnel Management, each of which has its own policies and procedures for determining whether beneficiaries are capable of managing their benefits. Sharing information about incapability determinations within SSA and among relevant federal agencies could increase the likelihood of each agency’s identifying potentially incapable beneficiaries. The committee called for SSA to ensure intra-agency communication regarding capability determinations with its different programs, and for SSA and other relevant federal agencies to explore mechanisms to facilitate ongoing interagency communications regarding the capability of beneficiaries.
By their nature, SSA capability determinations are dichotomous, meaning beneficiaries are deemed either capable or incapable of managing their benefits. When information about a beneficiary’s financial performance is insufficient to determine the need for a representative payee, the use of a supervised direct payment option may be helpful, the report says. Under such a model, benefits are paid directly to the beneficiary, but an individual is designated to supervise the beneficiary’s expenditures. These supervisors can observe and assess the beneficiary’s use of his or her benefits, permitting more accurate determination of the beneficiary’s capability in indeterminate or borderline cases. They also can provide guidance and instruction to beneficiaries on managing their benefits and help respond to the challenges posed by the fluctuations in some beneficiaries’ financial competence and performance. In addition, supervised direct payment may enable beneficiaries who might otherwise require the appointment of a representative payee to manage or direct the management of their benefits to meet their basic needs, thus maximizing their decisional autonomy. The committee recommended that SSA implement a demonstration project to evaluate the efficacy of a supervised direct payment option for qualified beneficiaries.
Data are limited on the effectiveness of current SSA processes for identifying beneficiaries who should be evaluated for capability and on the accuracy of capability determinations among those identified for evaluation. The committee called for the SSA to develop and implement an ongoing measurement and evaluation process to quantify and track the accuracy of capability determinations and to inform and improve its policies and procedure for identifying beneficiaries who are incapable of managing their benefits.
The study by the Institute of Medicine of the National Academies of Sciences, Engineering, and Medicine was sponsored by the U.S. Social Security Administration. The Academies are private, nonprofit institutions that provide independent, objective analysis and advice to the nation to solve complex problems and inform public policy decisions related to science, technology, and medicine. They operate under an 1863 congressional charter to the National Academy of Sciences, signed by President Lincoln. For more information, visit http://national-academies.org. A roster follows.
Jennifer Walsh, Senior Media Relations Officer
Emily Raschke, Media Relations Assistant
Office of News and Public Information
202-334-2138; e-mail email@example.com
Copies of Informing Social Security’s Process for Financial Capability Determination are available from the National Academies Press on the Internet at http://www.nap.edu or by calling 202-334-3313 or 1-800-624-6242. Reporters may obtain a copy from the Office of News and Public Information (contacts listed above).
THE NATIONAL ACADEMIES OF SCIENCES, ENGINEERING, AND MEDICINE
Institute of Medicine
Board on the Health of Select Populations
Committee to Evaluate the Social Security Administration's (SSA)
Capability Determination Process for Adult Beneficiaries
Paul S. Appelbaum, M.D.* (chair)
Elizabeth Dollard Professor of Psychiatry, Medicine, and Law
Director, Division of Law, Ethics, and Psychiatry
New York State Psychiatric Institute and Columbia University Medical Center
New York City
Karen E. Anderson, M.D., M.P.H
Director, Huntington's Disease Care, Education, and Research Center
Associate Professor of Psychiatry and Neurology
Georgetown University Medical Center
MedStar Georgetown University Hospital
Maria P. Aranda, Ph.D., M.S.W., M.P.A, LCSW
School of Social Work
University of Southern California
Nancy Bagatell, Ph.D., OTR/L
Division of Occupational Science and Occupational Therapy
University of North Carolina
Julie Birkenmaier, Ph.D., M.S.W., LCSW
School of Social Work
Saint Louis University
Nancy Neveloff Dubler, LL.B.
Professor Emerita, Albert Einstein College of Medicine, Yeshiva University
Consultant for Ethics, New York City Health and Hospital Corporation
Adjunct Professor, Division of Medical Ethics, Langone Medical Center, New York University
New York City
Laura B. Dunn, M.D.
Director, Geriatric Psychiatry Fellowship Training Program
Department of Psychiatry and Behavioral Sciences
Alan M. Jette, Ph.D., M.P.H.*
Professor of Health Policy and Management
School of Public Health
David A. Loewenstein, Ph.D.
Director, Psychological Services and Neuropsychology Laboratory, Mount Sinai Medical Center Professor, Department of Psychiatry and Behavioral Sciences
Miller School of Medicine
University of Miami
Marc A. Norman, Ph.D.
Director, Neuropsychiatry/Epilepsy Clinical Evaluation Program
Professor, Medical Neuropsychology
University of California
Eldar Shafir, Ph.D.
William Stewart Tod Professor of Psychology and Public Affairs
Department of Psychology and the Woodrow Wilson School of Public and International Affairs
Kelly A. Thompson, J.D.
Thompson Wildhack PLC
Carol Mason Spicer, Ph.D.
*Member, National Academy of Medicine